Analysis of long-term observations of the large group of Russian patients with Hunter syndrome (mucopolysaccharidosis type II)

Abstract Background This article presents the results of long-term observations and comparative analysis of genotype-phenotype features in a large group of patients (227 males and one female) with a severe, intermediate and mild form of Hunter syndrome, evaluating the quality and span of their lives...

Full description

Saved in:
Bibliographic Details
Main Authors: Alla Nikolaevna Semyachkina (Author), Elena Yurievna Voskoboeva (Author), Ekaterina Alexandrovna Nikolaeva (Author), Ekaterina Yurievna Zakharova (Author)
Format: Book
Published: BMC, 2021-03-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_8f29f164769c470496d68d7ccc4d6e4a
042 |a dc 
100 1 0 |a Alla Nikolaevna Semyachkina  |e author 
700 1 0 |a Elena Yurievna Voskoboeva  |e author 
700 1 0 |a Ekaterina Alexandrovna Nikolaeva  |e author 
700 1 0 |a Ekaterina Yurievna Zakharova  |e author 
245 0 0 |a Analysis of long-term observations of the large group of Russian patients with Hunter syndrome (mucopolysaccharidosis type II) 
260 |b BMC,   |c 2021-03-01T00:00:00Z. 
500 |a 10.1186/s12920-021-00922-1 
500 |a 1755-8794 
520 |a Abstract Background This article presents the results of long-term observations and comparative analysis of genotype-phenotype features in a large group of patients (227 males and one female) with a severe, intermediate and mild form of Hunter syndrome, evaluating the quality and span of their lives, as well as their ability to social adaptation. Methods We used electrophoresis of glycosaminoglycans of urine, determination of the activity of lysosomal enzymes in plasma, in dried blood spots according to the generally accepted method and DNA analysis. Results The clinical symptomatology of 228 patients with Hunter syndrome was characterized by growth retardation, lesions of the bronchopulmonary, cardiovascular, nervous systems, etc. Thirty-five patients had an attenuated form of the disease. DNA was available from all patients. 19 patients from 10 families had a mild form of the disease. 42 patients from 41 families had an intermediate form of the disease. All other patients had a severe form of the disease. We provide brief clinical examples of some patients with a mild form of Hunter syndrome. Currently, 113 patients with Hunter syndrome receive enzyme replacement therapy (idursulfase or idursulfase beta). Conclusion The long-term study of the large number of patients with Hunter syndrome helped identify disease-associated variants leading to severe and mild forms of the disease. The treatment effect and successful social adaptation of patients with a mild form of Hunter syndrome were revealed. 
546 |a EN 
690 |a Mucopolysaccharidosis 
690 |a Hunter syndrome 
690 |a Clinical and genetic analysis 
690 |a Social adaptation 
690 |a Internal medicine 
690 |a RC31-1245 
690 |a Genetics 
690 |a QH426-470 
655 7 |a article  |2 local 
786 0 |n BMC Medical Genomics, Vol 14, Iss 1, Pp 1-18 (2021) 
787 0 |n https://doi.org/10.1186/s12920-021-00922-1 
787 0 |n https://doaj.org/toc/1755-8794 
856 4 1 |u https://doaj.org/article/8f29f164769c470496d68d7ccc4d6e4a  |z Connect to this object online.